Alkermes (ALKS) EVP David Gaffin sells 2,034 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Alkermes plc. executive David Joseph Gaffin, EVP and Chief Legal Officer of Alkermes, Inc., reported an open-market sale of 2,034 Ordinary Shares on July 6, 2026 at $54.03 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 19, 2025. Following this sale, he directly holds 227,490 Ordinary Shares, so the transaction represents only a small fraction of his overall position.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,034 shares ($109,897)
Net Sell
1 txn
Insider
Gaffin David Joseph
Role
EVP, CLO, Alkermes, Inc.
Sold
2,034 shs ($110K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 2,034 | $54.03 | $110K |
Holdings After Transaction:
Ordinary Shares — 227,490 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 2,034 shares
Sale price per share: $54.03 per share
Shares held after transaction: 227,490 shares
+3 more
6 metrics
Shares sold
2,034 shares
Open-market sale on July 6, 2026
Sale price per share
$54.03 per share
Ordinary Shares transaction
Shares held after transaction
227,490 shares
Direct ownership following sale
Transaction code
S
Open-market or private sale of non-derivative securities
Net share direction
-2,034 shares
Net-sell across reported transactions
Trading plan adoption date
November 19, 2025
Rule 10b5-1 plan used for this sale
Key Terms
Ordinary Shares, open-market sale, Rule 10b5-1 trading plan, Form 4, +1 more
5 terms
open-market sale financial
"reported an open-market sale of 2,034 Ordinary Shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Rule 10b5-1 trading plan regulatory
"executed under a pre-arranged Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Form 4 regulatory
"routine insider sale disclosed in a Form 4 filing with updated"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
beneficial ownership financial
"updated post-transaction holdings reflect his beneficial ownership stake"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did Alkermes (ALKS) report for David Joseph Gaffin?
Alkermes reported that EVP and Chief Legal Officer David Joseph Gaffin sold 2,034 Ordinary Shares in an open-market transaction at $54.03 per share. This was a routine insider sale disclosed in a Form 4 filing with updated post-transaction holdings.
What role does David Joseph Gaffin hold at Alkermes (ALKS)?
David Joseph Gaffin serves as Executive Vice President and Chief Legal Officer of Alkermes, Inc. His position makes his equity transactions subject to SEC reporting, which is why his sale of Ordinary Shares appears in this Form 4 filing.